Cargando…
Efficacy and Safety of Remimazolam Besylate versus Dexmedetomidine for Sedation in Non-Intubated Older Patients with Agitated Delirium After Orthopedic Surgery: A Randomized Controlled Trial [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377341/ https://www.ncbi.nlm.nih.gov/pubmed/35978858 http://dx.doi.org/10.2147/DDDT.S385435 |
Ejemplares similares
-
Efficacy and Safety of Remimazolam Besylate versus Dexmedetomidine for Sedation in Non-Intubated Older Patients with Agitated Delirium After Orthopedic Surgery: A Randomized Controlled Trial
por: Deng, Yang, et al.
Publicado: (2022) -
The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography
por: Tan, Dan‐Dan, et al.
Publicado: (2022) -
Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study
por: Tang, Yun, et al.
Publicado: (2023) -
Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study
por: Tang, Yun, et al.
Publicado: (2022) -
Remimazolam for Sedation During Fiberoptic Intubation in an Adolescent
por: Hughes, Mitchell, et al.
Publicado: (2023)